Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$868M |
| 2 |
Amazon
AMZN
|
+$726M |
| 3 |
UnitedHealth
UNH
|
+$571M |
| 4 |
Rivian
RIVN
|
+$559M |
| 5 |
TJX Companies
TJX
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$762M |
| 3 |
L3Harris
LHX
|
+$742M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$497M |
| 5 |
Texas Instruments
TXN
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
1201
DELISTED
Marathon Oil Corporation
MRO
| $2.63M | ﹤0.01% |
160,216
+80,574
| +101% | +$1.3M |
|
|
FSTX
1202
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $2.63M | ﹤0.01% |
522,158
-156,233
| -23% | -$942K |
|
1203
Evergy
EVRG
$19.4B
| $2.62M | ﹤0.01% |
38,222
-52,731
| -58% | -$3.43M |
|
1204
Pinnacle West Capital
PNW
$12.4B
| $2.62M | ﹤0.01% |
37,037
-3,560
| -9% | -$239K |
|
|
LTC
1205
LTC Properties
LTC
$2.13B
| $2.61M | ﹤0.01% |
76,525
+10,503
| +16% | +$351K |
|
1206
Pinduoduo
PDD
$126B
| $2.59M | ﹤0.01% |
44,351
-21,461
| -33% | -$1.69M |
|
1207
PENN Entertainment
PENN
$2.84B
| $2.59M | ﹤0.01% |
49,876
+233
| +0.5% | +$14.1K |
|
1208
Darling Ingredients
DAR
$9.32B
| $2.58M | ﹤0.01% |
37,279
+20,922
| +128% | +$1.52M |
|
1209
PG&E
PCG
$39B
| $2.53M | ﹤0.01% |
208,163
-5,505
| -3% | -$64.5K |
|
|
Y
1210
DELISTED
Alleghany Corp
Y
| $2.51M | ﹤0.01% |
3,759
-529
| -12% | -$352K |
|
1211
Stoneridge
SRI
$200M
| $2.48M | ﹤0.01% |
125,479
-1,579,379
| -93% | -$33.4M |
|
1212
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $2.46M | ﹤0.01% |
28,300
+17,807
| +170% | +$1.54M |
|
1213
Pentair
PNR
$10.6B
| $2.45M | ﹤0.01% |
33,556
+4,729
| +16% | +$348K |
|
1214
Plexus
PLXS
$6.43B
| $2.43M | ﹤0.01% |
25,306
+22,399
| +771% | +$2.07M |
|
1215
Packaging Corp of America
PKG
$22.2B
| $2.42M | ﹤0.01% |
17,767
-938
| -5% | -$126K |
|
1216
Kinross Gold
KGC
$27.7B
| $2.41M | ﹤0.01% |
414,861
+189,020
| +84% | +$1.13M |
|
1217
Pacira BioSciences
PCRX
$1.04B
| $2.39M | ﹤0.01% |
39,665
-22,278
| -36% | -$1.23M |
|
1218
Supernus Pharmaceuticals
SUPN
$2.7B
| $2.38M | ﹤0.01% |
81,621
+7,494
| +10% | +$227K |
|
1219
Warner Bros
WBD
$64.3B
| $2.38M | ﹤0.01% |
100,939
-57,920
| -36% | -$1.44M |
|
1220
HEICO Corp Class A
HEI.A
$36B
| $2.36M | ﹤0.01% |
18,386
-4,389
| -19% | -$558K |
|
1221
Federal Realty Investment Trust
FRT
$10.9B
| $2.36M | ﹤0.01% |
17,305
+4,288
| +33% | +$544K |
|
1222
Charles River Laboratories
CRL
$11.3B
| $2.36M | ﹤0.01% |
6,252
+127
| +2% | +$49.3K |
|
1223
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.7B
| $2.33M | ﹤0.01% |
22,804
+14,398
| +171% | +$1.43M |
|
1224
ZTO Express
ZTO
$18.2B
| $2.32M | ﹤0.01% |
82,074
-1,488
| -2% | -$44.4K |
|
1225
National Health Investors
NHI
$3.79B
| $2.31M | ﹤0.01% |
40,080
-2,878
| -7% | -$159K |
|
Similar funds
Janus Henderson Group's Q4 2021 Portfolio in Review
As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
- Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
- Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
- Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
- Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
- Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
- Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.
Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.